Carisma Therapeutics (CARM) Institutional Ownership $1.00 +0.03 (+3.09%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Carisma Therapeutics (NASDAQ:CARM)CurrentInstitutional OwnershipPercentage44.27%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$104.48KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.59M Get CARM Insider Trade Alerts Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CARM Institutional Buying and Selling by Quarter Ad Porter & CompanyThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Carisma Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails9/16/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% 8/15/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% 8/15/2024TPG GP A LLC842,031$1.28M0.0%-42.0%2.027% 8/9/2024Renaissance Technologies LLC139,360$212K0.0%-38.3%0.335% 5/10/2024Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803% 5/7/2024Empowered Funds LLC26,984$61K0.0%-43.9%0.065% 2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102% 10/13/2023 SG Americas Securities LLC13,653$58K0.0%N/A0.034% 9/21/2023Barclays PLC5,312$47K0.0%N/A0.013% 8/4/2023American International Group Inc.12,834$113K0.0%N/A0.032% 7/27/2023EA Series Trust40,434$355K0.0%N/A0.100% 6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422% 5/15/2023Wittenberg Investment Management Inc.46,703$145K0.1%N/A0.459% 5/12/2023Deuterium Capital Management LLC51,256$159K0.2%N/A0.504% 5/10/2023Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145% 5/3/2023Jump Financial LLC17,542$54K0.0%N/A0.172% 5/1/2023Virtu Financial LLC15,335$48K0.0%N/A0.151% 4/27/2023Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195% 4/24/2023 Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291% 4/14/2023BML Capital Management LLC411,398$1.28M1.1%N/A4.041% (Data available from 1/1/2016 forward) CARM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CARM shares? During the previous two years, 18 institutional investors and hedge funds held shares of Carisma Therapeutics. The most heavily invested institutionals were Trustees of The University of Pennsylvania ($3.67M), Vanguard Group Inc. ($3.59M), TPG GP A LLC ($1.28M), BML Capital Management LLC ($1.28M), EA Series Trust ($355K), Renaissance Technologies LLC ($212K), and Deuterium Capital Management LLC ($159K).Learn more on CARM's institutional investors. What percentage of Carisma Therapeutics stock is owned by institutional investors? 44.27% of Carisma Therapeutics stock is owned by institutional investors. Learn more on CARM's institutional investor holdings. Which institutional investors have been buying Carisma Therapeutics stock? Of the 15 institutional investors that purchased Carisma Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Trustees of The University of Pennsylvania ($2.18M), BML Capital Management LLC ($411.40K), Point72 Asia Singapore Pte. Ltd. ($52.01K), Deuterium Capital Management LLC ($51.26K), Wittenberg Investment Management Inc. ($46.70K), EA Series Trust ($40.43K), and Blodgett Wealth Advisors LLC ($29.66K). How much institutional buying is happening at Carisma Therapeutics? Institutional investors have bought a total of 2,924,846 shares in the last 24 months. This purchase volume represents approximately $9.32M in transactions. Which Carisma Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Carisma Therapeutics stock in the last 24 months: TPG GP A LLC ($609.85K), Trustees of The University of Pennsylvania ($507.74K), Renaissance Technologies LLC ($86.64K), and Empowered Funds LLC ($21.15K). How much institutional selling is happening at Carisma Therapeutics? Institutional investors have sold a total of 1,225,372 shares in the last 24 months. This volume of shares sold represents approximately $2.59M in transactions. Related Companies Exagen Major Shareholders Cytosorbents Major Shareholders TherapeuticsMD Major Shareholders Aspira Women's Health Major Shareholders Sensei Biotherapeutics Major Shareholders Incannex Healthcare Major Shareholders Black Diamond Therapeutics Major Shareholders LifeVantage Major Shareholders Checkpoint Therapeutics Major Shareholders Sagimet Biosciences Major Shareholders This page (NASDAQ:CARM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
